Workflow
第一医药去年营收增长5.26%至19.15亿元,新增2家宠物特色门店

Core Viewpoint - The company reported a revenue growth of 5.26% to 1.915 billion yuan and a net profit increase of 82.65% to 163 million yuan for the year 2024 [1] Group 1: Financial Performance - Revenue increased by 5.26% to 1.915 billion yuan [1] - Net profit rose by 82.65% to 163 million yuan [1] Group 2: Store Expansion and Business Development - The number of retail stores reached 206, with a net increase of 35 stores, including 2 new pet specialty stores [4] - The company opened its first pet-friendly pharmacy in June 2024, recognized by the Shanghai Commercial Industry Association [4] - The company added 53 new medical insurance stores, with over 60% of stores covered by medical insurance, exceeding the average coverage in Shanghai [4] - A total of 24 new franchise stores were added, with franchise sales exceeding 50 million yuan for the year [4] Group 3: New Business Initiatives - The company ranked among the top 4 in O2O sales in Shanghai, showing significant improvement [4] - Cross-border sales of health products were initiated through its subsidiary, enhancing the product line and obtaining qualifications for cross-border drug sales [4] Group 4: Strategic Partnerships and Services - The company transferred 49% of its wholly-owned subsidiary, Deep Sea Medicine, to develop SPD business for wholesale growth [5] - A traditional Chinese medicine decoction service center was established, aiming to provide more personalized services [5] Group 5: Digital Transformation - The company’s membership mini-program recorded over 43,000 new registrations in 2024 [6] - A modern intelligent logistics center is under construction, expected to enhance logistics efficiency and reduce costs by 2025 [6]